ANXA5 and metabolic syndrome: The drop in circulating Gr1low monocytes under the P-407 treatment could not be explained by a selective toxic effect of the dyslipidemia as the percentages of the Annexin V+/PI+ monocytes were not markedly different between the two monocyte subpopulations, irrespective of the treatment (Figure 1E).